Skip to main content

Key Product Details

Species Reactivity

Mouse

Applications

Western Blot

Label

DyLight 350 (Excitation = 353 nm, Emission = 432 nm)

Antibody Source

Polyclonal Sheep IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse LILRC1
Gln17-Asn248
Accession # AAY44811

Specificity

Detects mouse LILRC1 in direct ELISAs and Western blots. In direct ELISAs, approximately 30% cross-reactivity with recombinant rat (rr) LILRC1 is observed and approximately 15% cross-reactivity with rrLILRC2 is observed.

Clonality

Polyclonal

Host

Sheep

Isotype

IgG

Applications for LILRC1 Antibody [DyLight 350]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: LILRC1

Long Name

Leukocyte Immunoglobulin-like Receptor C1

Alternate Names

LILRA5

Gene Symbol

Lilra5

Additional LILRC1 Products

Product Documents for LILRC1 Antibody [DyLight 350]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for LILRC1 Antibody [DyLight 350]



DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...